---
# System prepended metadata

title: 'US Dermal Fillers Market Size, Share, Growth and Demand by 2029'

---

"US Dermal Fillers" is not a specific brand or product name for dermal fillers. Instead, it appears to be a term referring to dermal fillers that are available in the United States. As mentioned earlier, several [[dermal](https://www.fortunebusinessinsights.com/u-s-dermal-fillers-market-107015)](https://) filler brands have been approved by the FDA for use in the United States, including Juvederm, Restylane, Belotero, Radiesse, Sculptra, and more. These brands offer a range of [[dermal fillers](https://www.fortunebusinessinsights.com/de/us-hautf-llermarkt-107015)] with different formulations and purposes, such as reducing wrinkles, restoring volume, and enhancing facial features.



The term "US Dermal Fillers" simply signifies that these are dermal fillers that are approved and available for use within the United States. However, it's important to consult with a healthcare professional or dermatologist to determine the specific dermal filler that is best suited for your individual needs and goals. They can provide you with personalized recommendations based on your desired outcomes and help you understand the options available in the US market.



Key Players:

·        Allergan Aesthetics (AbbVie Inc.) (U.S.)

·        Revance Therapeutics, Inc. (U.S.)

·        Merz [[Pharma](https://www.fortunebusinessinsights.com/jp/%E7%B1%B3%E5%9B%BD%E3%81%AE%E7%9A%AE%E8%86%9A%E5%85%85%E5%A1%AB%E5%89%A4%E5%B8%82%E5%A0%B4-107015)](Germany)

·        GALDERMA (Switzerland)

·        Suneva Medical (U.S.)

·        Prollenium Medical Technologies (Canada)

·        Bioxis pharmaceuticals (France)

·        Sinclair (U.K.)

Read More:

U.S. Dermal Fillers Market Size, Share